Neurotoxicity Screening Battery

Neurotoxicity screening battery comprehensively assesses pharmaceutical neurological effects employing behavioural and mechanistic studies. Motor activity assessment detects hyperactivity or sedation. Cognitive testing identifies learning impairment. Electrophysiology measures neurological function. Histopathology identifies neurodegenerative changes.

Regulatory expectations emphasise neurotoxicity assessment for suspect compounds. Paediatric CNS vulnerability warrants enhanced evaluation. Clinical monitoring detects neurological adverse events. Post-approval surveillance identifies unexpected neurotoxicity. Emerging technologies enable molecular neurotoxicity assessment.